Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer follo

The efficacy of prior EGFR-TKI treatment in patients with <i>EGFR-</i>mutant NSCLC who experience disease progression could be a predictive marker for ABCP rather than Chemo efficacy.

Authors

Institutions

Publication Details

Journal
ESMO Real World Data and Digital Oncology
Published
2025-05-20
DOI
https://doi.org/10.1016/j.esmorw.2025.100152
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer follo

Koji Date, S. Matsumoto, Tomohiko Fukuda, Yasuhiro Gotô et al.
ESMO Real World Data and Digital Oncology
Lung Cancer Treatments and Mutations
article

Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer follo

Koji Date, S. Matsumoto, Tomohiko Fukuda, Yasuhiro Gotô, Hisashi Tanaka, Akihiro Yoshimura, Akira Nakao, Takayo Ota, Yusuke Chihara, Koichi Takayama, Reiko Honda, Tae Hata, Makoto Hibino, Yasushi Okazaki, Naoki Furuya, Kenji Morimoto, Shinsuke Ogusu, Tadaaki Yamada, Tomohiro Oba, Taishi Harada, Koji Mikami, K Masubuchi
article en

Abstract

The efficacy of prior EGFR-TKI treatment in patients with <i>EGFR-</i>mutant NSCLC who experience disease progression could be a predictive marker for ABCP rather than Chemo efficacy.

ESMO Real World Data and Digital OncologyVol. 8
Kansai Medical University (JP), Fujita Health University (JP), Hirosaki University (JP), St. Marianna University School of Medicine (JP), Saga University (JP), Kyoto Prefectural University of Medicine (JP), Fukuoka University Hospital (JP), Rakuwakai Otowa Hospital (JP), Kyoto College of Medical Science (JP), Suita Tokushukai Hospital (JP), Fukuyama City Hospital (JP), Yokufukai Hospital (JP), Kyoto first Red Cross hospital (JP), Izumi City General Hospital (JP), Asahi General Hospital (JP), Saitama Red Cross Hospital (JP), Japanese Red Cross Society Kyoto Daini Hospital (JP), Hyogo Prefectural Cancer Center (JP), Nagasaki University (JP)
Good health and well-being
Openalex Percentile: Top 82%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.